Bayer-backed Boundless Bio sees stock fall 8% after $100M IPO [Seeking Alpha]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: Seeking Alpha
Shares of Boundless opened at $14.25 after being priced at $16 per share, hitting an early high of $15 and then a low of $14.10. The stock recently sold at $14.72 at around 1:45 p.m. ET. Boundless offered 6.25M shares at $16 per share. Underwriters were granted a 30-day option to buy up to 937,500 additional shares to cover any over-allotments. Goldman Sachs, Leerink Partners, Piper Sandler and Guggenheim Securities are serving as bookrunners on the deal. Bayer Healthcare ( OTCPK:BAYZF OTCPK:BAYRY ) held a 9% stake in the company ahead of the IPO. Based in San Diego, Boundless Bio is developing ecDNA-directed therapeutics called ecDTx along with a companion diagnostic for the treatment of oncogene amplified tumors. The company's lead product, BBI-355, is in Phase 1/2 testing. Boundless first filed for the IPO in early March. Recommended For You More Trending News Recommended For You More Trending News Related Stocks In The News Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Billionaire Miami Dolphins owner wants to make South Florida more like Manhattan—'I still love a challenge' [Fortune]Fortune
- Inside the life of a sports banker: Top dealmakers from Goldman Sachs, PJT, Raine, and more break down the job. [Business Insider]Business Insider
- 15 Best States to Retire in The US Financially [Yahoo! Finance]Yahoo! Finance
- 10 Best Technology Dividend Aristocrats to Buy [Yahoo! Finance]Yahoo! Finance
- Galvanize Real Estate Acquires First Asset in Pioneering Profitable Decarbonization Strategy [Yahoo! Finance]Yahoo! Finance
GS
Earnings
- 4/15/24 - Beat
GS
Sec Filings
- 4/26/24 - Form 424B2
- 4/26/24 - Form 424B2
- 4/26/24 - Form 485BPOS
- GS's page on the SEC website